Nothing Special   »   [go: up one dir, main page]

AU2002211061A1 - T cell receptor transfer into a candidate effector cell or precursor thereof - Google Patents

T cell receptor transfer into a candidate effector cell or precursor thereof

Info

Publication number
AU2002211061A1
AU2002211061A1 AU2002211061A AU1106102A AU2002211061A1 AU 2002211061 A1 AU2002211061 A1 AU 2002211061A1 AU 2002211061 A AU2002211061 A AU 2002211061A AU 1106102 A AU1106102 A AU 1106102A AU 2002211061 A1 AU2002211061 A1 AU 2002211061A1
Authority
AU
Australia
Prior art keywords
cell
precursor
candidate effector
receptor transfer
cell receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211061A
Inventor
Johan Herman Frederik Falkenburg
Maria Huberta Margaretha Heemsker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Leiden filed Critical Universiteit Leiden
Publication of AU2002211061A1 publication Critical patent/AU2002211061A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002211061A 2000-09-18 2001-09-18 T cell receptor transfer into a candidate effector cell or precursor thereof Abandoned AU2002211061A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00203232 2000-09-18
EP00203232A EP1188825A1 (en) 2000-09-18 2000-09-18 T cell receptor transfer into a candidate effector cell or a precursor thereof
PCT/NL2001/000693 WO2002022790A1 (en) 2000-09-18 2001-09-18 T cell receptor transfer into a candidate effector cell or a precursor thereof

Publications (1)

Publication Number Publication Date
AU2002211061A1 true AU2002211061A1 (en) 2002-03-26

Family

ID=8172037

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211061A Abandoned AU2002211061A1 (en) 2000-09-18 2001-09-18 T cell receptor transfer into a candidate effector cell or precursor thereof

Country Status (5)

Country Link
US (1) US20030219463A1 (en)
EP (2) EP1188825A1 (en)
AU (1) AU2002211061A1 (en)
CA (1) CA2422597A1 (en)
WO (1) WO2002022790A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
EP1795599A1 (en) * 2005-12-09 2007-06-13 Schuler, Gerold, Prof. Dr. Methods for generating antigen-specific effector T cells
EP1878744A1 (en) * 2006-07-13 2008-01-16 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
WO2008111430A1 (en) * 2007-03-09 2008-09-18 Takara Bio Inc. METHOD FOR PRODUCING γδT CELL POPULATION
EP2098536A1 (en) 2008-03-05 2009-09-09 4-Antibody AG Isolation and identification of antigen- or ligand-specific binding proteins
ITMI20080508A1 (en) * 2008-03-27 2009-09-28 Istituto Nazionale Di Genetica Molecolare HEMATOPOIETIC CELLS EXPRESSING KRTCAP3 PROTEIN AND BINDERS FOR KRTCAP3 PROTEIN
ITMI20080865A1 (en) * 2008-05-13 2009-11-14 Istituto Naz Di Genetica Molecolare Ingm HEMATOPOIETAL CELLS EXPRESSING SUSD3 PROTEIN AND BINDERS FOR SUSD3 PROTEIN
US10464987B2 (en) 2009-10-06 2019-11-05 Abbvie Inc. Human single-chain T cell receptors
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
WO2013033626A2 (en) 2011-08-31 2013-03-07 Trustees Of Dartmouth College Nkp30 receptor targeted therapeutics
JP6389166B2 (en) 2012-05-07 2018-09-12 トラスティーズ・オブ・ダートマス・カレッジ Anti-B7-H6 antibodies, fusion proteins, and methods of using them
CN102875666B (en) * 2012-09-05 2014-07-09 南方医科大学 Tuberculosis antigen specificity TCR (T cell receptor), recombinant retroviral vector thereof and application
CA2954168C (en) 2013-08-02 2023-09-19 The Regents Of The University Of California Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
CN107106670A (en) * 2014-10-31 2017-08-29 宾夕法尼亚大学董事会 Method and composition for the T cell of modification
MA44907A (en) * 2015-09-11 2018-07-18 Agenus Inc GENETICALLY MODIFIED HOST CELLS AND THEIR METHODS OF USE
WO2018090057A1 (en) * 2016-11-14 2018-05-17 Fred Hutchinson Cancer Research Center High affinity merkel cell polyomavirus t antigen-specific tcrs and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2205881A1 (en) * 1997-07-09 1999-01-09 Gilbert Mazza Tcr scfv and biological applications thereof
CA2360046A1 (en) * 1999-01-28 2000-08-03 Lawrence S. Lamb, Jr. In vitro activated gamma delta lymphocytes

Also Published As

Publication number Publication date
EP1320581A1 (en) 2003-06-25
EP1188825A1 (en) 2002-03-20
CA2422597A1 (en) 2002-03-21
US20030219463A1 (en) 2003-11-27
WO2002022790A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2002211061A1 (en) T cell receptor transfer into a candidate effector cell or precursor thereof
AU2001236177A1 (en) T cell receptor libraries
EP2267439B8 (en) Biosensor for quantifying a substrate
AU2002343349A1 (en) Uninterruptible transfer switch
AU3195499A (en) Feature tracking using a dense feature array
AU2002228883A1 (en) Tile array computers
AU2001283032A1 (en) Chemical feeder
AU6680100A (en) Transferring device
AU2001267078A1 (en) Alkaline cell
AU4407200A (en) Functional memory based on a trie structure
AUPR242801A0 (en) A contact centre management system
AU2001284706A1 (en) Female condom employing tensegrity principle
AU2002324989A1 (en) Utility capacity transfer system
AU2001266973A1 (en) A cold cathode
AU2002243281A1 (en) Cell transfer device
AU2001267076A1 (en) Alkaline cell
AU2002221873A1 (en) Epothilone resistant cell lines
AU2002245107A1 (en) Improved biochip
AU2001245700A1 (en) Transfer microdissection
AU6199001A (en) Battery, especially a flat cell
AU2002357294A1 (en) Sequential data transfer detection
AU7318700A (en) Novel transaldolase gene
AU1882900A (en) Assay for homocysteine
AU2001265832A1 (en) Parallel manipulator provided with a truss structure
AU1990301A (en) A thin battery